Literature DB >> 8277071

Electrocardiographic diagnosis of left ventricular hypertrophy by the time-voltage integral of the QRS complex.

P M Okin1, M J Roman, R B Devereux, J S Borer, P Kligfield.   

Abstract

OBJECTIVES: This study was conducted to test the hypothesis that the time-voltage integral of the QRS complex can improve the electrocardiographic (ECG) identification of left ventricular hypertrophy.
BACKGROUND: Standard ECG criteria have exhibited poor sensitivity for left ventricular hypertrophy at acceptable levels of specificity. However, left ventricular mass may be more closely related to the time-voltage integral of the summed left ventricular dipole than to QRS duration or voltages used in standard ECG criteria.
METHODS: Standard 12-lead ECGs, orthogonal lead signal-averaged ECGs and echocardiograms were obtained in 62 male control subjects without left ventricular hypertrophy and 51 men with left ventricular hypertrophy defined by echocardiographic criteria (indexed left ventricular mass > 125 g/m2). Voltage of the QRS complex was integrated over the total QRS duration in leads X, Y and Z to calculate the time-voltage integral of each orthogonal lead, of the maximal spatial vector complex and of the horizontal, frontal and sagittal plane vector complexes.
RESULTS: At matched specificity of 99%, the 73% (37 of 51) sensitivity of the time-voltage integral of the vector QRS complex in the horizontal plane was significantly greater than the 10% sensitivity of the Romhilt-Estes point score, the 16% sensitivity of QRS duration alone, the 22% sensitivity of Cornell voltage, the 33% sensitivity of the 12-lead sum of QRS voltage and the 37% sensitivity of Sokolow-Lyon voltage (each p < 0.001). Sensitivity of the horizontal plane time-voltage integral was also greater than the 10% to 51% sensitivity of the time-voltage integral calculated in the individual X, Y or Z leads (p < 0.01 to < 0.001), the 18% and 35% sensitivity of the time-voltage integrals of the frontal and sagittal plane vectors (p < 0.001) and the 49% sensitivity of the time-voltage integral of the maximal spatial vector complex calculated from all three orthogonal leads (p < 0.001). Comparison of receiver operating characteristic curves confirmed that the superior performance of the horizontal plane time-voltage integral relative to standard and other signal-averaged criteria was independent of partition value selection.
CONCLUSIONS: These findings suggest that use of the time-voltage integral of the QRS complex, a method that can be readily implemented on commercially available computerized ECG systems, can improve the accuracy of ECG methods for the identification of left ventricular hypertrophy.

Entities:  

Mesh:

Year:  1994        PMID: 8277071     DOI: 10.1016/0735-1097(94)90511-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

1.  Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Jonathan Chrispin; Aditya Jain; Elsayed Z Soliman; Eliseo Guallar; Alvaro Alonso; Susan R Heckbert; David A Bluemke; João A C Lima; Saman Nazarian
Journal:  J Am Coll Cardiol       Date:  2014-03-19       Impact factor: 24.094

2.  Electrophysiological ventricular substrate of stroke: a prospective cohort study in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  John A Johnson; Kazi T Haq; Katherine J Lutz; Kyle K Peters; Kevin A Paternostro; Natalie E Craig; Nathan W L Stencel; Lila F Hawkinson; Maedeh Khayyat-Kholghi; Larisa G Tereshchenko
Journal:  BMJ Open       Date:  2021-09-03       Impact factor: 3.006

3.  Determination of left ventricular mass in systemic hypertension: comparison of standard and signal averaged electrocardiography.

Authors:  D Lacroix; M A Nader; C Savoye; D Klug; R Logier; S Kacet; J Lekieffre
Journal:  Br Heart J       Date:  1995-09

4.  Cohort Study of ECG Left Ventricular Hypertrophy Trajectories: Ethnic Disparities, Associations With Cardiovascular Outcomes, and Clinical Utility.

Authors:  Carlos Iribarren; Alfred D Round; Meng Lu; Peter M Okin; Edward J McNulty
Journal:  J Am Heart Assoc       Date:  2017-10-05       Impact factor: 5.501

5.  A new electrocardiogram marker to identify patients at low risk for ventricular tachyarrhythmias: sum magnitude of the absolute QRST integral.

Authors:  Larisa G Tereshchenko; Alan Cheng; Barry J Fetics; Barbara Butcher; Joseph E Marine; David D Spragg; Sunil Sinha; Darshan Dalal; Hugh Calkins; Gordon F Tomaselli; Ronald D Berger
Journal:  J Electrocardiol       Date:  2010-11-20       Impact factor: 1.438

6.  Beat-to-beat spatiotemporal variability in the T vector is associated with sudden cardiac death in participants without left ventricular hypertrophy: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Jonathan W Waks; Elsayed Z Soliman; Charles A Henrikson; Nona Sotoodehnia; Lichy Han; Sunil K Agarwal; Dan E Arking; David S Siscovick; Scott D Solomon; Wendy S Post; Mark E Josephson; Josef Coresh; Larisa G Tereshchenko
Journal:  J Am Heart Assoc       Date:  2015-01-19       Impact factor: 5.501

7.  Electrocardiographic deep terminal negativity of the P wave in V(1) and risk of sudden cardiac death: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Larisa G Tereshchenko; Charles A Henrikson; Nona Sotoodehnia; Dan E Arking; Sunil K Agarwal; David S Siscovick; Wendy S Post; Scott D Solomon; Josef Coresh; Mark E Josephson; Elsayed Z Soliman
Journal:  J Am Heart Assoc       Date:  2014-11-21       Impact factor: 5.501

8.  Assessment of Left Ventricular Hypertrophy (LVH) Criteria by Surface Electrocardiography in a Sample of Iraqi Patients with Systemic Arterial Hypertension.

Authors:  Rafid Bashir Altaweel; Maher Abdulla Radhi
Journal:  Med Arch       Date:  2020-12

9.  Evaluation of Different Criteria in the Diagnosis of Left Ventricular Hypertrophy by Electrocardiogram in Comparison With Echocardiogram.

Authors:  João Pedro Marcato; Felipe Senra Santos; André Gama Palone; Gustavo Lenci Marques
Journal:  Cureus       Date:  2022-06-27

10.  Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER-Prevention Randomized Clinical Trial.

Authors:  Sandra Costa Fuchs; Carlos E Poli-de-Figueiredo; José A Figueiredo Neto; Luiz César N Scala; Paul K Whelton; Francisca Mosele; Renato Bandeira de Mello; José F Vilela-Martin; Leila B Moreira; Hilton Chaves; Marco Mota Gomes; Marcos R de Sousa; Ricardo Pereira E Silva; Iran Castro; Evandro José Cesarino; Paulo Cesar Jardim; João Guilherme Alves; André Avelino Steffens; Andréa Araujo Brandão; Fernanda M Consolim-Colombo; Paulo Ricardo de Alencastro; Abrahão Afiune Neto; Antônio C Nóbrega; Roberto Silva Franco; Dario C Sobral Filho; Alexandro Bordignon; Fernando Nobre; Rosane Schlatter; Miguel Gus; Felipe C Fuchs; Otávio Berwanger; Flávio D Fuchs
Journal:  J Am Heart Assoc       Date:  2016-12-13       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.